147 related articles for article (PubMed ID: 30227356)
1. Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients.
Fernández-Ochoa Á; Quirantes-Piné R; Borrás-Linares I; Gemperline D; ; Alarcón Riquelme ME; Beretta L; Segura-Carretero A
J Pharm Biomed Anal; 2019 Jan; 162():82-90. PubMed ID: 30227356
[TBL] [Abstract][Full Text] [Related]
2. Discovering new metabolite alterations in primary sjögren's syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology.
Fernández-Ochoa Á; Borrás-Linares I; Quirantes-Piné R; Alarcón-Riquelme ME; Beretta L; Segura-Carretero A;
J Pharm Biomed Anal; 2020 Feb; 179():112999. PubMed ID: 31780281
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of amino acids and acylcarnitines combined with untargeted metabolomics using ultra-high performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
Roy C; Tremblay PY; Bienvenu JF; Ayotte P
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():40-9. PubMed ID: 27240302
[TBL] [Abstract][Full Text] [Related]
4. Nonylphenol Toxicity Evaluation and Discovery of Biomarkers in Rat Urine by a Metabolomics Strategy through HPLC-QTOF-MS.
Zhang YX; Yang X; Zou P; Du PF; Wang J; Jin F; Jin MJ; She YX
Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187439
[TBL] [Abstract][Full Text] [Related]
5. Quantification of acylglycines in human urine by HPLC electrospray ionization-tandem mass spectrometry and the establishment of pediatric reference interval in local Chinese.
Fong BM; Tam S; Leung KS
Talanta; 2012 Jan; 88():193-200. PubMed ID: 22265487
[TBL] [Abstract][Full Text] [Related]
6. Endometriosis is associated with aberrant metabolite profiles in plasma.
Letsiou S; Peterse DP; Fassbender A; Hendriks MM; van den Broek NJ; Berger R; O DF; Vanhie A; Vodolazkaia A; Van Langendonckt A; Donnez J; Harms AC; Vreeken RJ; Groothuis PG; Dolmans MM; Brenkman AB; D'Hooghe TM
Fertil Steril; 2017 Mar; 107(3):699-706.e6. PubMed ID: 28259259
[TBL] [Abstract][Full Text] [Related]
7. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous ultra-high performance liquid chromathograpy-electrospray ionization-quadrupole-time of flight mass spectrometry quantification of endogenous anandamide and related N-acylethanolamides in bio-matrices.
Ottria R; Ravelli A; Gigli F; Ciuffreda P
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 May; 958():83-9. PubMed ID: 24705535
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Disturbances in Urinary and Plasma Samples from Seven Different Systemic Autoimmune Diseases Detected by HPLC-ESI-QTOF-MS.
Fernández-Ochoa Á; Brunius C; Borrás-Linares I; Quirantes-Piné R; Cádiz-Gurrea ML; Precisesads Clinical Consortium ; Alarcón Riquelme ME; Segura-Carretero A
J Proteome Res; 2020 Aug; 19(8):3220-3229. PubMed ID: 32460496
[TBL] [Abstract][Full Text] [Related]
10. Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.
Ottria A; Hoekstra AT; Zimmermann M; van der Kroef M; Vazirpanah N; Cossu M; Chouri E; Rossato M; Beretta L; Tieland RG; Wichers CGK; Stigter E; Gulersonmez C; Bonte-Mineur F; Berkers CR; Radstake TRDJ; Marut W
Front Immunol; 2020; 11():822. PubMed ID: 32528464
[TBL] [Abstract][Full Text] [Related]
11. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction.
Zoerner AA; Batkai S; Suchy MT; Gutzki FM; Engeli S; Jordan J; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():161-71. PubMed ID: 21752730
[TBL] [Abstract][Full Text] [Related]
13. Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women.
Fanelli F; Mezzullo M; Belluomo I; Di Lallo VD; Baccini M; Ibarra Gasparini D; Casadio E; Mastroroberto M; Vicennati V; Gambineri A; Morselli-Labate AM; Pasquali R; Pagotto U
Mol Metab; 2017 May; 6(5):406-415. PubMed ID: 28462075
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profile perturbations of serum, lung, bronchoalveolar lavage fluid, spleen and feces in LPS-induced acute lung injury rats based on HPLC-ESI-QTOF-MS.
Wang T; Lin S; Liu R; Li H; Liu Z; Zhang X; Xu H; Li Q; Bi K
Anal Bioanal Chem; 2020 Feb; 412(5):1215-1234. PubMed ID: 31940090
[TBL] [Abstract][Full Text] [Related]
15. Serum metabolite differences detected by HILIC UHPLC-Q-TOF MS in systemic sclerosis.
Sun C; Zhu H; Wang Y; Han Y; Zhang D; Cao X; Alip M; Nie M; Xu X; Lv L; Feng X; Sun L; Wang D
Clin Rheumatol; 2023 Jan; 42(1):125-134. PubMed ID: 36127550
[TBL] [Abstract][Full Text] [Related]
16. Integrated plasma and urine metabolomics coupled with HPLC/QTOF-MS and chemometric analysis on potential biomarkers in liver injury and hepatoprotective effects of Er-Zhi-Wan.
Yao W; Gu H; Zhu J; Barding G; Cheng H; Bao B; Zhang L; Ding A; Li W
Anal Bioanal Chem; 2014 Nov; 406(28):7367-78. PubMed ID: 25245419
[TBL] [Abstract][Full Text] [Related]
17. UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.
Chen YX; Zhang XJ; Huang J; Zhou SJ; Liu F; Jiang LL; Chen M; Wan JB; Yang DZ
J Pharm Biomed Anal; 2016 Mar; 121():141-150. PubMed ID: 26808063
[TBL] [Abstract][Full Text] [Related]
18. Pressurized CEC coupled with QTOF-MS for urinary metabolomics.
Wu Q; Yu X; Wang Y; Gu X; Ma X; Lv W; Chen Z; Yan C
Electrophoresis; 2014 Sep; 35(17):2470-8. PubMed ID: 24789083
[TBL] [Abstract][Full Text] [Related]
19. Multiplatform metabolomics provides insight into the molecular basis of chronic kidney disease.
Kordalewska M; Macioszek S; Wawrzyniak R; Sikorska-Wiśniewska M; Śledziński T; Chmielewski M; Mika A; Markuszewski MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():49-57. PubMed ID: 30999273
[TBL] [Abstract][Full Text] [Related]
20. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
